Koch Holger M, Bolt Hermann M, Preuss Ralf, Angerer Jürgen
Institute and Outpatient Clinic of Occupational, Social and Environmental Medicine, University of Erlangen-Nuremberg, Schillerstrasse 25/29, 91054, Erlangen, Germany.
Arch Toxicol. 2005 Jul;79(7):367-76. doi: 10.1007/s00204-004-0642-4. Epub 2005 Feb 8.
The metabolism of di(2-ethylhexyl)phthalate (DEHP) in humans was studied after three doses of 0.35 mg (4.7 microg/kg), 2.15 mg (28.7 microg/kg) and 48.5 mg (650 microg/kg) of D4-ring-labelled DEHP were administered orally to a male volunteer. Two new metabolites, mono(2-ethyl-5-carboxypentyl)phthalate (5cx-MEPP) and mono[2-(carboxymethyl)hexyl]phthalate (2cx-MMHP) were monitored for 44 h in urine and for 8 h in serum for the high-dose case, in addition to the three metabolites previously analysed: mono(2-ethyl-5-hydroxyhexyl)phthalate (5OH-MEHP), mono(2-ethyl-5-oxohexyl)phthalate (5oxo-MEHP) and mono(2-ethylhexyl)phthalate (MEHP). For the medium- and low-dose cases, 24 h urine samples were analysed. Up to 12 h after the dose, 5OH-MEHP was the major urinary metabolite, after 12 h it was 5cx-MEPP, and after 24 h it was 2cx-MMHP. The elimination half-lives of 5cx-MEHP and 2cx-MMHP were between 15 and 24 h. After 24 h 67.0% (range: 65.8-70.5%) of the DEHP dose was excreted in urine, comprising 5OH-MEHP (23.3%), 5cx-MEPP (18.5%), 5oxo-MEHP (15.0%), MEHP (5.9%) and 2cx-MMHP (4.2%). An additional 3.8% of the DEHP dose was excreted on the second day, comprising 2cx-MMHP (1.6%), 5cx-MEPP (1.2%), 5OH-MEHP (0.6%) and 5oxo-MEHP (0.4%). In total about 75% of the administered DEHP dose was excreted in urine after two days. Therefore, in contrast to previous studies, most of the orally administered DEHP is systemically absorbed and excreted in urine. No dose dependency in metabolism and excretion was observed. The secondary metabolites of DEHP are superior biomonitoring markers compared to any other parameters, such as MEHP in urine or blood. 5OH-MEHP and 5oxo-MEHP in urine reflect short-term and 5cx-MEHP and 2cx-MMHP long-term exposure. All secondary metabolites are unsusceptible to contamination. Furthermore, there are strong hints that the secondary oxidised DEHP metabolites-not DEHP or MEHP-are the ultimate developmental toxicants.
对一名男性志愿者口服给予三剂分别为0.35毫克(4.7微克/千克)、2.15毫克(28.7微克/千克)和48.5毫克(650微克/千克)的D4环标记邻苯二甲酸二(2-乙基己基)酯(DEHP)后,研究了其在人体中的代谢情况。除了之前分析的三种代谢物:单(2-乙基-5-羟基己基)邻苯二甲酸酯(5OH-MEHP)、单(2-乙基-5-氧代己基)邻苯二甲酸酯(5oxo-MEHP)和单(2-乙基己基)邻苯二甲酸酯(MEHP)外,对于高剂量组,还在尿液中监测了44小时、在血清中监测了8小时两种新的代谢物,即单(2-乙基-5-羧基戊基)邻苯二甲酸酯(5cx-MEPP)和单[2-(羧甲基)己基]邻苯二甲酸酯(2cx-MMHP)。对于中剂量和低剂量组,分析了24小时尿液样本。给药后长达12小时,5OH-MEHP是主要的尿液代谢物,12小时后是5cx-MEPP,24小时后是2cx-MMHP。5cx-MEHP和2cx-MMHP的消除半衰期在15至24小时之间。24小时后,67.0%(范围:65.8 - 70.5%)的DEHP剂量经尿液排出,其中包括5OH-MEHP(23.3%)、5cx-MEPP(18.5%)、5oxo-MEHP(15.0%)、MEHP(5.9%)和2cx-MMHP(4.2%)。另外3.8%的DEHP剂量在第二天排出,包括2cx-MMHP(1.6%)、5cx-MEPP(1.2%)、5OH-MEHP(0.6%)和5oxo-MEHP(0.4%)。两天后,总共约75%的给药DEHP剂量经尿液排出。因此,与之前的研究不同,口服的DEHP大部分被全身吸收并经尿液排出。未观察到代谢和排泄的剂量依赖性。与尿液或血液中的MEHP等任何其他参数相比,DEHP的次级代谢物是更好的生物监测标志物。尿液中的5OH-MEHP和5oxo-MEHP反映短期暴露,5cx-MEHP和2cx-MMHP反映长期暴露。所有次级代谢物均不易受污染。此外,有强烈迹象表明,氧化的DEHP次级代谢物而非DEHP或MEHP是最终的发育毒物。